JOHNSON & JOHNSON JNJ

Healthcare

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

NYSE:JNJ - Post by User

JOHNSON & JOHNSON

Bullboard Posts

Post by d80jcranton May 30, 2013 11:31am

496 Views

Post# 21460976

Price Target $98.00

That is awesome that JNJ has a new price target of $98.00 I wonder what the chances are that they do a 2:1 split or maybe split up the company like Abbott Labs did?

P.S. I also run a group called " Dividend Paying Stocks Feel free to join if you like. Thanks

Bullboard Posts

Spin Master and Jason Kelce partner on new Hatchimals release